Clinics for Sale and Investment in Bucharest

The company is the national market leader in professional podology in Romania, operating within a category that has emerged only within the past decade. Leadership was established in its first year by surpassing the annual revenue of a long-standing incumbent, highlighting both strong execution and an early-mover advantage. The market remains structurally underpenetrated, with less than 15% of the addressable population currently accessing podology services, compared to 40–60% in Western Europe, implying a 3–5x organic growth runway independent of market share gains. The business serves a base of over 5,100 active patients, generating approximately 19,300 visits annually (~1,600 per month), with consistently high satisfaction levels—over 95% of clients rate their experience 5/5 based on a large internal survey sample. The revenue model is centered on in-clinic medical services with strong recurrence dynamics, as chronic conditions typically require follow-up visits every 4–8 weeks. Unit economics are well validated, with a 24-month patient lifetime value of approximately 1,150 RON against a fully loaded customer acquisition cost of 132 RON, resulting in a rapid payback period of roughly three weeks. A core pillar of the investment case is the significant operating leverage embedded in the current setup. The flagship clinic is built to support approximately 3,200 visits per month but is currently operating at around 50% utilization. With fixed costs such as lease, equipment, and baseline staffing already covered, incremental revenue flows at an estimated ~80% contribution margin. As a result, increasing utilization toward capacity can drive EBITDA margins from approximately 12% to 25%+ without additional capital expenditure. The company generates approximately EUR 1.2 million in annual revenue, with gross margins around 60% and EBITDA margins of 12% at current utilization (normalized for founder compensation). The business is debt-free, with no external bank financing, and operates under a clean single-shareholder structure. A key competitive moat is its in-house training academy, which addresses a critical talent bottleneck in the Romanian podology market. While traditional pedicurists often resist formal employment structures, the company recruits medically trained assistants and upskills them into certified podology technicians through its proprietary curriculum. This creates a scalable and defensible talent pipeline, reduces dependency on the external labor market, generates an additional revenue stream through training, and establishes a meaningful barrier to entry for competitors. Additional defensibility is reinforced through proprietary clinical protocols (including comprehensive treatment frameworks), standardized operating procedures across all services, a robust and growing patient database with full clinical histories, and a proven marketing infrastructure. Operations are supported by a team of approximately 30 clinical and administrative staff, with processes sufficiently systematized to run independently of daily founder involvement. The founder brings over a decade of entrepreneurial and operational experience across multiple markets and is supported by a capable senior team spanning operations, marketing, and technology. Key person risk is actively mitigated through documented processes, the internal talent pipeline, and planned leadership expansion, including the addition of a COO to support multi-site scaling. Over time, the founder is expected to transition toward a strategic leadership role as the network expands. The business is fully compliant from a regulatory standpoint, operating as a licensed medical entity with all required authorizations in place. With a proven single-location model, strong unit economics, and a ready talent pipeline, the company is now operationally prepared to expand into multiple locations, with the first satellite clinic already in development and a clear blueprint for replication.

Unlike most other clinics, we want to find out what is causing the skin condition before treating it. The skin is the largest living organ in the human body, and most illnesses (such as autoimmune disease, which is on the rise owing to stress), allergies, or diseases present as symptoms in the skin. We at JEUNVIE HEALTH AND WELLBEING wish to assist you in looking at the issues from the inside out. Our monthly clientele ranges from 100 to 200 valued clients, and our treatments cost from GBP 100 to 1500. What distinguishes us is that we look after the general wellbeing if the patient from inside out.

The brand Intel-Scan is a home-based diagnosis tool in the form of a mobile application that is integrated with artificial intelligence using voice analysis to detect missing body frequencies. Categories: • Preventive health. • Home based health services. • Digital health. Record voice: AI gives you in seconds: • Full body reporting. • Immunity status. • 7 chakra status. • 5 element status. • Covid risk calculation. • Organ risk calculation. • Multiple treatment options: as per the stage of the disease and recommends list of pharmacies, path labs, doctors and hospitals near by and options for online consultation. Business model is mainly B2C. A parallel health care system platform that is both: 1. Preventive in nature with early and accurate Diagnosis-secondary prevention as per. WHO guidelines: 1984 Geneva Convention. 2. Curative: with online doctors, path labs, pharmacies, and hospitals. 3. Home based: all services delivered at Home. No hospital visits required. A common platform for: • Diagnosis tools Home Based. • End users. • Path labs. • Pharmacies. • Doctors. • Hospitals. Advantages- Home based health care services inclusive of: • Diagnosis at home using mobile phone app-Intel-Scan. • Lab tests. • Procuring medicines. • Consulting doctors online. • Visiting hospitals with online appointment. • Ambulance services. Unique selling proposition. • World’s first Ever tool that fulfills WHO guidelines for secondary prevention (early diagnosis) • Unique technology in early diagnosis and screening. • Patented technology in preventive health care for early diagnosis and screening. • No competitor's. • Only full body scan with reporting in 30 sec@ home using AI and voice analysis. • Beneficial in pandemic situations as a non contact diagnosis tool for viral and other infections. • Covid diagnosis sitting at home. • Covid mass screening – up to 5 crore people in one day. • Safer -no radiation hazard. • Scalable. • Potential of mass adoption.

The brand Intel-Scan is a home-based diagnosis tool in the form of a mobile application that is integrated with artificial intelligence using voice analysis to detect missing body frequencies. Categories: • Preventive health. • Home based health services. • Digital health. Record voice: AI gives you in seconds: • Full body reporting. • Immunity status. • 7 chakra status. • 5 element status. • Covid risk calculation. • Organ risk calculation. • Multiple treatment options: as per the stage of the disease and recommends list of pharmacies, path labs, doctors and hospitals near by and options for online consultation. Business model is mainly B2C. A parallel health care system platform that is both: 1. Preventive in nature with early and accurate Diagnosis-secondary prevention as per. WHO guidelines: 1984 Geneva Convention. 2. Curative: with online doctors, path labs, pharmacies, and hospitals. 3. Home based: all services delivered at Home. No hospital visits required. A common platform for: • Diagnosis tools Home Based. • End users. • Path labs. • Pharmacies. • Doctors. • Hospitals. Advantages- Home based health care services inclusive of: • Diagnosis at home using mobile phone app-Intel-Scan. • Lab tests. • Procuring medicines. • Consulting doctors online. • Visiting hospitals with online appointment. • Ambulance services. Unique selling proposition. • World’s first Ever tool that fulfills WHO guidelines for secondary prevention (early diagnosis) • Unique technology in early diagnosis and screening. • Patented technology in preventive health care for early diagnosis and screening. • No competitor's. • Only full body scan with reporting in 30 sec@ home using AI and voice analysis. • Beneficial in pandemic situations as a non contact diagnosis tool for viral and other infections. • Covid diagnosis sitting at home. • Covid mass screening – up to 5 crore people in one day. • Safer -no radiation hazard. • Scalable. • Potential of mass adoption.